CS255878B2 - Process for preparing embonates of qinolcarboxylic acids and derivatives thereof - Google Patents
Process for preparing embonates of qinolcarboxylic acids and derivatives thereof Download PDFInfo
- Publication number
- CS255878B2 CS255878B2 CS865351A CS535186A CS255878B2 CS 255878 B2 CS255878 B2 CS 255878B2 CS 865351 A CS865351 A CS 865351A CS 535186 A CS535186 A CS 535186A CS 255878 B2 CS255878 B2 CS 255878B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- acid
- derivatives
- group
- acids
- embonates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/11—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/105—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic
- C07C65/15—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups polycyclic with carboxyl groups on a condensed ring system containing more than two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853525335 DE3525335A1 (de) | 1985-07-16 | 1985-07-16 | Embonate von chinoloncarbonsaeuren und ihren derivaten |
Publications (2)
Publication Number | Publication Date |
---|---|
CS535186A2 CS535186A2 (en) | 1987-07-16 |
CS255878B2 true CS255878B2 (en) | 1988-03-15 |
Family
ID=6275883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS865351A CS255878B2 (en) | 1985-07-16 | 1986-07-14 | Process for preparing embonates of qinolcarboxylic acids and derivatives thereof |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0209000B1 (da) |
JP (1) | JPH0772177B2 (da) |
KR (1) | KR940002823B1 (da) |
AR (1) | AR242570A1 (da) |
AT (1) | ATE55600T1 (da) |
AU (1) | AU582255B2 (da) |
BR (1) | BR8603333A (da) |
CA (1) | CA1262350A (da) |
CS (1) | CS255878B2 (da) |
DE (2) | DE3525335A1 (da) |
DK (1) | DK168042B1 (da) |
ES (1) | ES2000678A6 (da) |
FI (1) | FI88389C (da) |
GR (1) | GR861823B (da) |
HU (1) | HU194151B (da) |
IE (1) | IE58750B1 (da) |
IL (1) | IL79399A (da) |
NZ (1) | NZ216815A (da) |
PL (1) | PL149651B1 (da) |
ZA (1) | ZA865256B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3705621C2 (de) * | 1986-02-25 | 1997-01-09 | Otsuka Pharma Co Ltd | Heterocyclisch substituierte Chinoloncarbonsäurederivate |
DE19633480A1 (de) * | 1996-08-20 | 1998-02-26 | Bayer Ag | Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren |
SI1594500T1 (sl) * | 2003-02-10 | 2011-02-28 | Bayer Schering Pharma Ag | Zdravljenje bakterijskih bolezni dihalnih organov z lokalno aplikacijo fluorokinolonov |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2397903A (en) * | 1944-09-19 | 1946-04-02 | Vick Chemical Company | Methylene-bis-2 hydroxy-3 naphthoates |
US2641610A (en) * | 1950-10-27 | 1953-06-09 | May & Baker Ltd | Quaternary ammonium salts |
JPS5762259A (en) * | 1980-09-05 | 1982-04-15 | Kyorin Pharmaceut Co Ltd | Preparation of substituted quinolinecarboxylic acid derivative |
US4382937A (en) * | 1981-02-27 | 1983-05-10 | Dainippon Pharmaceutical Co., Ltd. | Naphthyridine derivatives and their use as anti-bacterials |
ES8304117A1 (es) * | 1981-06-11 | 1983-02-16 | Warner Lambert Co | "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina". |
DE3525108A1 (de) * | 1985-06-07 | 1986-12-11 | Bayer Ag, 5090 Leverkusen | Antibakteriell wirksame chinoloncarbonsaeureester |
-
1985
- 1985-07-16 DE DE19853525335 patent/DE3525335A1/de not_active Withdrawn
-
1986
- 1986-07-02 DE DE8686109036T patent/DE3673476D1/de not_active Expired - Lifetime
- 1986-07-02 EP EP86109036A patent/EP0209000B1/de not_active Expired - Lifetime
- 1986-07-02 AT AT86109036T patent/ATE55600T1/de not_active IP Right Cessation
- 1986-07-11 JP JP61162170A patent/JPH0772177B2/ja not_active Expired - Lifetime
- 1986-07-11 NZ NZ216815A patent/NZ216815A/xx unknown
- 1986-07-11 AU AU60062/86A patent/AU582255B2/en not_active Expired
- 1986-07-14 FI FI862942A patent/FI88389C/fi not_active IP Right Cessation
- 1986-07-14 GR GR861823A patent/GR861823B/el unknown
- 1986-07-14 CA CA000513667A patent/CA1262350A/en not_active Expired
- 1986-07-14 IL IL79399A patent/IL79399A/xx not_active IP Right Cessation
- 1986-07-14 CS CS865351A patent/CS255878B2/cs not_active IP Right Cessation
- 1986-07-15 ZA ZA865256A patent/ZA865256B/xx unknown
- 1986-07-15 BR BR8603333A patent/BR8603333A/pt unknown
- 1986-07-15 HU HU862915A patent/HU194151B/hu unknown
- 1986-07-15 PL PL1986260626A patent/PL149651B1/pl unknown
- 1986-07-15 KR KR1019860005709A patent/KR940002823B1/ko not_active IP Right Cessation
- 1986-07-15 IE IE188986A patent/IE58750B1/en not_active IP Right Cessation
- 1986-07-15 DK DK335386A patent/DK168042B1/da not_active IP Right Cessation
- 1986-07-16 AR AR86304525A patent/AR242570A1/es active
- 1986-07-16 ES ES8600335A patent/ES2000678A6/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK168042B1 (da) | 1994-01-24 |
CS535186A2 (en) | 1987-07-16 |
PL260626A1 (en) | 1987-06-15 |
CA1262350A (en) | 1989-10-17 |
DK335386D0 (da) | 1986-07-15 |
PL149651B1 (en) | 1990-03-31 |
EP0209000A3 (en) | 1988-05-25 |
FI88389C (fi) | 1993-05-10 |
AR242570A1 (es) | 1993-04-30 |
IE861889L (en) | 1987-01-16 |
GR861823B (en) | 1986-11-11 |
FI88389B (fi) | 1993-01-29 |
ATE55600T1 (de) | 1990-09-15 |
IL79399A0 (en) | 1986-10-31 |
IE58750B1 (en) | 1993-11-03 |
DE3673476D1 (de) | 1990-09-20 |
EP0209000A2 (de) | 1987-01-21 |
DE3525335A1 (de) | 1987-01-22 |
DK335386A (da) | 1987-01-17 |
HUT42427A (en) | 1987-07-28 |
AU6006286A (en) | 1987-01-22 |
BR8603333A (pt) | 1987-02-24 |
AU582255B2 (en) | 1989-03-16 |
IL79399A (en) | 1990-08-31 |
NZ216815A (en) | 1988-10-28 |
ZA865256B (en) | 1987-03-25 |
HU194151B (en) | 1988-01-28 |
KR870001210A (ko) | 1987-03-12 |
FI862942A (fi) | 1987-01-17 |
JPS6219569A (ja) | 1987-01-28 |
JPH0772177B2 (ja) | 1995-08-02 |
EP0209000B1 (de) | 1990-08-16 |
KR940002823B1 (ko) | 1994-04-04 |
FI862942A0 (fi) | 1986-07-14 |
ES2000678A6 (es) | 1988-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1273579A (en) | Bactericidal formulations for use in the area of veterinary medicine | |
US4762831A (en) | Antibacterial 1,8-bridged 4-quinolone-3-carboxylic acids | |
US6967205B1 (en) | Compounds with antibacterial and antiparasitic properties | |
CA2263584C (en) | Orally applicable formulation of quinolone or naphthyridone carboxylic acids | |
EP1355629B1 (en) | Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids | |
CS255878B2 (en) | Process for preparing embonates of qinolcarboxylic acids and derivatives thereof | |
EP0828715B1 (de) | N-oxide als antibakterielle mittel | |
IE43251B1 (en) | 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis | |
JP2000501110A (ja) | ピリド(3,2,1―ij)―1,3,4―ベンゾオキサジアジン | |
JPH0565512B2 (da) | ||
JPH03218312A (ja) | 動物用細菌感染症予防、治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF00 | In force as of 2000-06-30 in czech republic | ||
MK4A | Patent expired |
Effective date: 20010714 |